antisense

Roche

Biotech

Roche’s ph. 3 win tees up blockbuster fight with Novartis

The data set up talks with regulators about the path to approval for the Ionis-partnered, would-be blockbuster candidate sefaxersen.

Nick Paul Taylor Sep 23, 2026 3:50am

Ionis headquarters

Fierce Pharma

Ionis scores ‘breakthrough’ rare disease approval

Sep 4, 2026 11:18am

Pipette dripping water droplet with money symbol on it into test tube

AusperBio adds $120M series C to push hep B drug through ph. 3

Aug 28, 2026 10:26am

Brain scan neuroscience

AAIC: Biogen bolsters hopes for pivotal anti-tau push

Jul 14, 2026 9:15am

Brain and money connected by a thread on a white background

Ionis bags $30M from Recordati for ex-US rare disease rights

Jun 25, 2026 6:59am

positive negative up down good bad mixed

Biogen advances Alzheimer’s tau program despite midphase miss

May 14, 2026 8:35am